Skip to main content

Published locations for IBD risk ‘uncertain’ in biologic-treated AxSpA patients

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. IBD risk ‘uncertain’ in biologic-treated AxSpA patients

User login

  • Reset your password
  • /content/ibd-risk-uncertain-biologic-treated-axspa-patients
  • /internalmedicinenews/article/254197/ankylosing-spondylitis/ibd-risk-uncertain-biologic-treated-axspa
  • /rheumatologynews/article/254197/ankylosing-spondylitis/ibd-risk-uncertain-biologic-treated-axspa
  • /rheumatology/article/254197/ankylosing-spondylitis/ibd-risk-uncertain-biologic-treated-axspa
  • /internalmedicine/article/254197/ankylosing-spondylitis/ibd-risk-uncertain-biologic-treated-axspa